Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 42 min ago
Peer-reviewedLicence not statedTransplantation and cellular therapy

Population Pharmacokinetic Estimation of Melphalan Exposure Predicts Disease Control and Toxicity after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

  • Natalia Tijaro Ovalle1
  • Andrew Lin2
  • Nancy Cruz Sitner1
  • Ryan Schofield3
  • Brenden Bready4
  • Mithat Gonen4
  • A. Zara Herskovits3
  • Ross S. Firestone5,6
  • Hamza Hashmi5,6
  • Hani Hassoun5,6
  • Malin Hultcrantz5,6
  • Neha S. Korde5,6
17 more authors
  • Alexander M. Lesokhin5,6
  • Kylee Maclachlan5,6
  • Sham Mailankody5,6
  • Francesco Maura5,6
  • Maximillian Merz5,6
  • Sridevi Rajeeve5,6
  • Urvi A. Shah5,6
  • Caryln Rose Tan5,6
  • Saad Z. Usmani5,6
  • Miguel-Angel Perales1,6
  • Parastoo B. Dahi1,6
  • Eric M. Jurgens1,6
  • David J. Chung7
  • Michael Scordo1,6
  • Heather J. Landau1,6
  • Sergio A. Giralt1,6
  • Gunjan L. Shah1,6
7 affiliations
  1. 1Adult BMT Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
  2. 2Department of Pharmacy, Memorial Sloan Kettering Cancer Center
  3. 3Department of Pathology and Laboratory Medicine
  4. 4Department of Epidemiology and Biostatistics
  5. 5Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
  6. 6Department of Medicine, Weill Cornell Medical College
  7. 7Northwell Health Cancer Institute
Read full textDOICite

Related

  1. Real-world analysis of thromboprophylaxis use during autologous hematopoietic stem cell transplantation for multiple myeloma
    Hannah Lee, Ronald L. Paquette, Haein Kim +12
    HaematologicaPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  2. A Simplified Frailty Score Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation
    Chelby Wakefield, Curtis Marcoux, Denái R. Milton +19
    Transplantation and cellular therapyPeer-reviewedLicence not statedFull textGeneral medicinePMC
  3. Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cell Transplantation Program for Patients With Hematologic Malignancy in a Resource-Limited Center in Chile
    Blaz Lesina, Susana Calderón, Vivianne Torres +4
    Annals of TransplantationPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  4. ASSOCIATION BETWEEN INTERFERON-Γ LEVELS IN MOBILIZED HEMATOPOIETIC STEM CELL PRODUCTS AND LOSS OF RESPONSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
    Laura Gabriela CARDOSO, Letícia NAVARRO GORDAN FERREIRA MARTINS, Ana Luiza GOULART STARCK +4
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  5. PREDICTIVE FACTORS FOR HEMATOPOIETIC STEM CELL MOBILIZATION IN AUTOLOGOUS TRANSPLANTATION: DEFINING A PERIPHERAL CD34+ CUTOFF FOR SINGLE-SESSION SUCCESS
    Breno Aires Cadiele Oliana REICHERT, Celso ARRAIS, Raquel Valverde SOUSA +5
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ

Cite

BibTeXRIS
BibTeX
@article{ovalle2026population,
  title = {{Population Pharmacokinetic Estimation of Melphalan Exposure Predicts Disease Control and Toxicity after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma}},
  author = {Natalia Tijaro Ovalle and Andrew Lin and Nancy Cruz Sitner and Ryan Schofield and Brenden Bready and Mithat Gonen and A. Zara Herskovits and Ross S. Firestone and Hamza Hashmi and Hani Hassoun and Malin Hultcrantz and Neha S. Korde and Alexander M. Lesokhin and Kylee Maclachlan and Sham Mailankody and Francesco Maura and Maximillian Merz and Sridevi Rajeeve and Urvi A. Shah and Caryln Rose Tan and Saad Z. Usmani and Miguel-Angel Perales and Parastoo B. Dahi and Eric M. Jurgens and David J. Chung and Michael Scordo and Heather J. Landau and Sergio A. Giralt and Gunjan L. Shah},
  journal = {Transplantation and cellular therapy},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jtct.2026.10.015},
  url = {https://doi.org/10.1016/j.jtct.2026.10.015},
}
RIS
TY  - JOUR
TI  - Population Pharmacokinetic Estimation of Melphalan Exposure Predicts Disease Control and Toxicity after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
AU  - Natalia Tijaro Ovalle
AU  - Andrew Lin
AU  - Nancy Cruz Sitner
AU  - Ryan Schofield
AU  - Brenden Bready
AU  - Mithat Gonen
AU  - A. Zara Herskovits
AU  - Ross S. Firestone
AU  - Hamza Hashmi
AU  - Hani Hassoun
AU  - Malin Hultcrantz
AU  - Neha S. Korde
AU  - Alexander M. Lesokhin
AU  - Kylee Maclachlan
AU  - Sham Mailankody
AU  - Francesco Maura
AU  - Maximillian Merz
AU  - Sridevi Rajeeve
AU  - Urvi A. Shah
AU  - Caryln Rose Tan
AU  - Saad Z. Usmani
AU  - Miguel-Angel Perales
AU  - Parastoo B. Dahi
AU  - Eric M. Jurgens
AU  - David J. Chung
AU  - Michael Scordo
AU  - Heather J. Landau
AU  - Sergio A. Giralt
AU  - Gunjan L. Shah
PY  - 2026
DA  - 2026/10/13
JO  - Transplantation and cellular therapy
DO  - 10.1016/j.jtct.2026.10.015
UR  - https://doi.org/10.1016/j.jtct.2026.10.015
SN  - 2666-6375
SN  - 2666-6367
ER  -